A recombinant conjugated pneumococcal vaccine that protects against murine infections with a similar efficacy to Prevnar-13

The pneumococcal conjugate vaccine (PCV) strongly protects against vaccine serotypes, but the rapid expansion of non-vaccine serotype disease and the vaccine’s high expense has reduced its overall impact. We have developed Protein Glycan Coupling Technology (PGCT) as a flexible methodology for makin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:NPJ Vaccines
Main Authors: Reglinski, Mark, Ercoli, Giuseppe, Plumptre, Charlie, Kay, Emily, Petersen, Fernanda C., Paton, James C., Wren, Brendan W., Brown, Jeremy S.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6208403/
https://ncbi.nlm.nih.gov/pubmed/30393571
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41541-018-0090-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados